Hyrax vs. Haas Expander:
Which RPE Device
Is Right for Your Child?
Comprehensive clinical comparison of tooth-borne expansion devices, with evidence-based guidance on skeletal response, dentoalveolar changes, and optimal patient selection criteria.
TL;DR The Hyrax expander is a tooth-borne rapid palatal expansion device offering lower cost and non-invasive application, ideal for growing patients with favorable suture maturity. The Haas expander incorporates an acrylic palatal vault, potentially reducing dentoalveolar side effects. Selection depends on age, skeletal maturity, and desired expansion characteristics—MARPE is the evidence-backed alternative for adults and difficult cases.
Selecting the optimal rapid palatal expansion device remains a cornerstone decision in orthodontic treatment planning, particularly in mixed dentition patients. This article examines the clinical differences between the Hyrax and Haas expanders—two tooth-borne palatal expansion devices—and provides an evidence-based framework for device selection. Dr. Mark Radzhabov synthesizes contemporary research on dentoalveolar and skeletal outcomes to help clinicians match expansion protocol to patient age, skeletal maturity, and clinical goals. Understanding these distinctions ensures predictable results and minimizes undesired side effects.
What Is the Hyrax Expander and How Does It Differ
from the Haas Expander?
The Hyrax expander is a tooth-borne rapid palatal expansion device consisting of a central four-point screw mechanism anchored to the maxillary molars and premolars. The device employs stainless steel or titanium (Titan Hyrax®) expansion screws with built-in friction thread design and mechanical stops to prevent inadvertent reversal. The screw advances 0.25 mm per quarter turn, allowing controlled midpalatal suture separation when activated one full turn daily (1 mm/day). Additional holes in the appliance body ensure secure retention in dental acrylic, and the design minimizes material bulk, improving patient comfort and access for oral hygiene.
The Haas expander similarly anchors to posterior maxillary teeth but incorporates an acrylic palatal vault that contacts the hard palate across a broader surface area. This acrylic component was theoretically designed to distribute expansion forces more physiologically and potentially reduce buccal tipping of the anchor teeth. The Haas mechanism uses an identical central screw principle but relies on the palatal acrylic to transmit forces to skeletal structures. Clinical studies on expansion screw catalogues (such as Dentaurum and PSM BENEfit systems) confirm that both designs achieve wide expansion despite compact screw dimensions, with modern precision manufacturing ensuring even activation and mechanical reliability.
Both devices are non-invasive, removable appliances suitable for growing patients with open or maturing midpalatal sutures. Neither requires surgical intervention or implant placement. The choice between them hinges on dentoalveolar side-effect tolerance, structural support preferences, and cost considerations. Titanium variants (Titan Hyrax®) offer biocompatible alternatives for patients with metal sensitivities, though clinical efficacy does not differ meaningfully from stainless steel versions.
Skeletal Response and Dentoalveolar Changes:
What Does Research Show?
A prospective randomized clinical trial comparing conventional rapid palatal expansion (RPE) with miniscrew-assisted RPE (MARPE) in adolescents and young adults provides critical context for understanding tooth-borne device limitations. The study, which included 40 patients receiving identical 35-turn expansion protocols with low-dose cone-beam computed tomography assessment, revealed important skeletal differences. The MARPE group demonstrated greater nasal width increase in the molar region and greater palatine foramen expansion compared to tooth-borne RPE, indicating more efficient skeletal rather than dental compensation. Both Hyrax and Haas represent tooth-borne mechanisms and thus exhibit similar skeletal behavior to the conventional RPE group in this comparison: increased but constrained skeletal expansion, with compensatory buccal tipping of anchor teeth.
Dentoalveolar side effects are more pronounced with tooth-borne devices than with skeletal alternatives. The research documented that RPE groups showed greater buccal displacement of first premolar and molar root positions compared to MARPE. This indicates that anchor teeth bearing the expansion force experience measurable tipping and lateral root displacement—a consideration when treatment goals include precise molar positioning or when anchor tooth health is compromised. The Haas expander's acrylic vault theoretically mitigates some tipping by distributing force over a broader palatal area, though direct comparative studies between Hyrax and Haas remain limited in contemporary literature.
Midpalatal suture opening success rates reached 90–95% across both RPE and MARPE groups when proper expansion magnitude was applied, indicating that suture maturity—not device type—is the primary predictor of skeletal response. Younger patients (ages 7–11 years) with maximally open sutures experience predictable anterior midpalatal separation and maxillary width gain. In contrast, patients approaching or exceeding skeletal maturity often require higher activation cycles or alternative techniques (MARPE or surgical RPE) to achieve meaningful skeletal expansion. The choice between Hyrax and Haas therefore depends less on their capacity to open the suture and more on your tolerance for dental side effects and patient-specific anatomical factors.
How to Choose Between Hyrax and Haas:
Patient Selection Criteria
Age and skeletal maturity are the primary determinants of rapid palatal expansion device success. In mixed dentition patients aged 7–11 years with open midpalatal sutures, both the Hyrax and Haas expanders achieve excellent skeletal expansion and dentoalveolar correction. At this developmental window, suture patency is maximal, and orthopedic response is robust. A randomized controlled trial comparing a maxillary expander with differential opening (EDO) to the conventional Hyrax demonstrated significantly greater anterior midpalatal suture opening and intercanine expansion with specialized designs, though the standard Hyrax remains the evidence-supported baseline device. Choose the Hyrax when cost is a primary constraint, treatment compliance is uncertain, or you prefer maximum simplicity and minimal chair time for insertions and adjustments.
The Haas expander becomes the preferred choice when you anticipate significant dentoalveolar side effects (e.g., posterior crossbite with severe molar tipping, or when precise anchor tooth positioning is critical to final occlusal outcome). The acrylic palatal contact may reduce unwanted buccal displacement of premolars and molars, particularly in cases where the maxillary dentoalveolar base is already narrow or anchor tooth roots are compromised. However, the Haas requires longer fabrication time, greater acrylic adjustment, and higher material cost—typically 30–50% more expensive than tooth-borne Hyrax devices depending on laboratory fees.
For patients near or beyond skeletal maturity (age 12–14+ years), or those with previously failed RPE attempts, consider miniscrew-assisted rapid palatal expansion (MARPE) as documented in contemporary protocols. Unlike tooth-borne devices, MARPE provides purely skeletal force vectors without compensatory dental tipping, achieving greater nasal width increase and reduced anchor tooth displacement. Dr. Mark Radzhabov's clinical practice emphasizes that MARPE has become the standard recommendation for adolescents with fusion of the midpalatal suture or for any patient where dental side effects pose unacceptable clinical risk.
Expansion Screw Design and Material Considerations
Stainless Steel vs. Titanium
Modern expansion screws represent highly refined precision components engineered to ensure consistent, reversible activation and mechanical durability. Stainless steel expansion screws remain the gold standard for conventional Hyrax appliances, offering excellent strength-to-weight ratio, predictable friction characteristics on the screw thread, and proven long-term clinical performance across decades of clinical use. Dentaurum's standard hyrax® screw and PSM's BENEfit system both feature built-in stops and friction-calculated thread designs that prevent inadvertent reversal and ensure even screw opening even after extended activation periods.
Titanium expansion screws (Titan Hyrax®) emerged as a biocompatible alternative for patients with documented nickel sensitivity or metal allergy concerns. Titanium offers superior biocompatibility and reduced corrosion risk in the oral environment, though the material's slightly lower hardness requires careful handling during insertion. Clinical performance of titanium screws matches stainless steel equivalents when proper activation protocol is followed. The choice between materials is primarily patient-driven rather than clinically outcome-driven; both achieve identical expansion mechanics and skeletal response when properly activated at 1 mm daily. Cost varies by manufacturer and material, with titanium variants typically 15–25% more expensive.
Expansion screw precision is critical to clinical success. Catalogs from major manufacturers (Dentaurum, PSM BENEfit) emphasize that high-precision manufacturing and careful thread design ensure that the screw construction remains strong and stable throughout the entire activation period. Additional holes in the appliance body optimize retention in acrylic, preventing mechanical failure or screw loosening during patient activation. Modern designs also incorporate improved ergonomics for patient and clinician activation, with clearly marked activation points and smooth quarter-turn advancement mechanisms that minimize activation errors and improve compliance.
Practical Protocol: Activation, Monitoring, and Consolidation
from RPE to Orthodontic Treatment
Standard activation protocol for both Hyrax and Haas expanders involves one complete turn per day (1 mm/day expansion) for 6–10 days of active expansion, depending on case severity and treatment goals. Patients and caregivers require clear written and verbal instructions to ensure consistent daily activation and prevent over-activation or missed turns. Activation should ideally occur in the evening to allow natural overnight oral fluid shifts and reduce acute palatal discomfort. Chairside demonstration and take-home instruction sheets with numbered activation points minimize errors and improve compliance. Many clinicians provide a small activation key tool that patients keep at home, though some modern appliances feature ergonomic designs that allow direct finger-turn activation.
During active expansion phase (typically 6–10 days), patients may experience transient midline palatal discomfort, slight speech changes, or mild nasal airway sensation changes as the suture separates. These symptoms are expected and resolve within 48–72 hours post-expansion in most growing patients. Monitoring includes clinical evaluation of midline diastema opening (anterior maxillary incisors separate proportionally to suture opening), posterior crossbite correction, and absence of excessive dentoalveolar side effects. Intraoral photographs at baseline and immediately post-expansion document skeletal and dentoalveolar changes for case records.
Consolidation phase typically spans 3–6 months after active expansion ceases, allowing new bone formation across the opened suture and stabilization of dentoalveolar position. The appliance remains in place during consolidation to act as a passive retainer. Research using low-dose CBCT confirmed that skeletal gains stabilize over a 3-month consolidation period, with no significant rebound or relapse documented in growing patients. After consolidation, the expander is removed and fixed orthodontic treatment proceeds with comprehensive arch alignment. In cases where skeletal expansion remains incomplete after RPE, MARPE offers a viable subsequent step, though this scenario is uncommon in properly selected, growing patients.
Difficult Cases and When to Consider
Alternative Expansion Approaches
Despite correct patient selection, a small percentage of cases fail to achieve adequate skeletal expansion with tooth-borne RPE devices. Causes include inadequate suture maturity assessment, excessive dentoalveolar compensation masking skeletal response, low patient compliance with activation, or mechanical appliance failure. In these scenarios, clinicians must consider surgical-assisted rapid palatal expansion (SARPE) for adults or MARPE for adolescents with maturing sutures. SARPE is reserved for skeletally mature patients (typically age 16+) and involves surgical elevation of nasal and pterygoid soft tissues prior to RPE activation, allowing direct skeletal expansion without dental side effects. However, SARPE carries higher invasiveness and cost compared to tooth-borne or miniscrew-assisted alternatives.
Miniscrew-assisted rapid palatal expansion (MARPE) has emerged as the evidence-backed standard for adolescents approaching skeletal maturity or cases where dental tipping poses unacceptable risk. MARPE places two to four titanium miniscrews into the hard palate (often mid-palatal or paramedian positions) and attaches the expansion screw mechanism directly to skeletal anchorage rather than dental anchors. This configuration eliminates dental compensation and produces greater nasal width and skeletal expansion compared to tooth-borne RPE, as documented in randomized trials. MARPE requires specialized training and CBCT-guided surgical planning but offers superior skeletal outcomes and may reduce the need for orthognathic surgery in severe cases.
Patient compliance significantly impacts outcome across all RPE modalities. Inadequate daily activation, inconsistent turn frequency, or mechanical errors during screw advancement reduce skeletal response and prolong treatment duration. Clear pre-treatment counseling, written activation logs, and periodic compliance checks (e.g., measuring midline diastema at each visit) help ensure protocol adherence. For patients with documented compliance concerns or cognitive barriers to home activation, consider MARPE with fixed-attachment expansion mechanisms that eliminate patient-dependent daily activation and reduce relapse risk during the critical consolidation phase.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
What is the optimal age window for tooth-borne rapid palatal expansion (RPE) with the Hyrax expander?
Ages 7–11 years represent the ideal window for Hyrax expansion, when the midpalatal suture is maximally open and orthopedic response is most robust. Success rates remain high through early adolescence (ages 12–14) but decline significantly after age 15 as the suture begins to fuse.
How does the Haas expander reduce dentoalveolar side effects compared to the Hyrax?
The Haas incorporates an acrylic palatal vault that distributes expansion forces across a broader palatal area, theoretically reducing buccal tipping and root displacement of anchor teeth. Direct comparative trials remain limited, but the structural support may mitigate unwanted dental compensation in sensitive cases.
What is the expected dentoalveolar change (tooth tipping) with conventional tooth-borne RPE?
Tooth-borne RPE produces measurable buccal displacement of anchor teeth and their roots—approximately 2–4 mm of molar and premolar outward tipping during active expansion. This is compensatory and expected but may complicate final occlusal positioning if anchor teeth require incisal or cuspal precision.
How does MARPE differ from the Hyrax vs. Haas expander in skeletal outcome?
MARPE produces greater nasal width increase and skeletal expansion without dental compensation, as miniscrews anchor directly to bone rather than teeth. Research shows MARPE achieves significantly more efficient skeletal gains compared to tooth-borne RPE in identical patient populations.
Can the Hyrax expander successfully treat patients with fused or near-fused midpalatal sutures?
No. Fused or heavily ossified sutures resist tooth-borne expansion forces; activation produces dental tipping without skeletal opening. MARPE or surgical-assisted RPE (SARPE) are necessary alternatives for skeletally mature or advanced-maturity patients.
What happens if a patient misses daily Hyrax activations or forgets to turn the screw?
Missed or irregular activations reduce overall skeletal expansion and prolong treatment duration. Weekly compliance checks (measuring midline diastema) help identify adherence issues. Patients with poor compliance may benefit from MARPE with fixed-attachment mechanisms that eliminate daily home activation.
Which expansion screw material—stainless steel or titanium—produces better clinical outcomes?
Both materials achieve identical expansion mechanics and skeletal response. Titanium (Titan Hyrax®) is reserved for patients with nickel allergy or metal sensitivity; otherwise, stainless steel remains the cost-effective standard with proven long-term durability.
How long is the typical consolidation period after active RPE activation ceases?
Three to six months is the standard consolidation phase, allowing new bone formation across the opened midpalatal suture. Low-dose CBCT studies confirm skeletal gains stabilize within three months with minimal relapse in growing patients when the appliance remains in place as a passive retainer.
What is the main limitation of tooth-borne palatal expansion compared to skeletal methods?
Tooth-borne RPE produces compensatory dental tipping and cannot isolate true skeletal expansion, limiting its use in cases where precise molar positioning or anchor tooth preservation is critical. MARPE bypasses this limitation by using miniscrew anchorage for pure skeletal force vectors.
Should I recommend RPE, MARPE, or SARPE for a 14-year-old with severe transverse maxillary deficiency and maturing midpalatal suture?
MARPE is the evidence-backed choice for age 12–15 years with suture fusion risk. It provides superior skeletal expansion without dental side effects and avoids the cost and invasiveness of SARPE while outperforming tooth-borne RPE in skeletal efficiency and precision.
Both the Hyrax and Haas expanders remain viable options for growing patients, but clinical outcomes depend critically on proper patient selection and suture maturity assessment. The Hyrax offers cost-effectiveness and simplicity; the Haas provides structural support that may reduce dental tipping. For skeletally mature patients or complex cases, miniscrew-assisted rapid palatal expansion (MARPE) has emerged as the evidence-supported standard. Consult Dr. Mark Radzhabov's case review resources at Orthodontist Mark to refine your expansion protocol selection and optimize treatment outcomes across patient populations.
